Mrv1652310201623502D 12 13 0 0 1 0 999 V2000 -2.1434 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 0.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 1.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8520 0.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8520 0.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 5 4 1 1 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 5 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 7 12 1 0 0 0 0 M END > DB12287 > drugbank > C#CCO[C@H]1CN2CCC1CC2 > InChI=1S/C10H15NO/c1-2-7-12-10-8-11-5-3-9(10)4-6-11/h1,9-10H,3-8H2/t10-/m0/s1 > XVFJONKUSLSKSW-JTQLQIEISA-N > C10H15NO > 165.236 > 165.115364107 > 2 > 27 > 18.85535723024536 > 1 > 0 > 0 > 1 > (3R)-3-(prop-2-yn-1-yloxy)-1-azabicyclo[2.2.2]octane > 1.02 > 0.728281483333333 > -2.39 > 0 > 2 > 1 > 8.76082856449332 > 12.47 > 48.563 > 2 > 1 > 6.66e-01 g/l > talsaclidine > 1 > DB12287 > investigational > Talsaclidine > Talsaclidine $$$$